Introduction
Lip and oral cavity cancers represent the 16th overall and the 15th deadliest cancer worldwide with an increasing incidence in the last decades [1‐3]. It is estimated that in 2022 the number of lip and oral cavity cancer-related deaths worldwide will be 80,736 [2]. Similar to other head and neck cancer subtypes, the majority of cancers of the lip and oral cavity are squamous cell carcinomas (SCC) (> 90%) which are characterized by a high degree of local invasion and high rate of metastasis that directly affects the patient prognosis [4‐8]. The early diagnosis of lip and oral cavity cancer and premalignant lesions is essential [9]. In particular, lip squamous cell carcinoma (LSCC) can be prevented either by reducing exposure to solar ultraviolet (UV) radiation, which is its most common cause [10], or by screening for precancerous lesions [2]. Precancerous lesions of the lip and the oral cavity represent mucosal lesions, such as oral leukoplakia, oral erythroplakia, proliferative verrucous leukoplakia, oral submucous fibrosis, or actinic cheilitis (AC), while the latter may progress to SCC of the lip (LSCC) [11] depending on specific prognostic factors such as epithelial dysplasia (ED) [12‐14].
AC, also known as actinic cheilosis or solar cheilitis, is the most common precancerous lesion of lip and oral cavity cancers. AC was first described by Ayres in 1923 [15, 16] as a chronic inflammatory process that affects the lower lip in 95% of cases and is most commonly caused by chronic exposure to sunlight or artificial ultraviolet radiation [17]. Its clinical presentation includes dryness, erythema, and atrophy at the edge of the vermilion border of the lower lip in predominantly white middle-aged males [18]. AC can progress into invasive LSCC [17‐21] with an estimated incidence ranging from 1.4 to 36% over one to thirty year intervals. Some common risk factors associated with malignant transformation of AC are tobacco smoking, alcohol abuse, HPV, race, family, genetic predisposition, immunosuppressive status, poor diet, and socioeconomic factors [21]. Histopathological features of AC include hyperplasia, acanthosis or atrophy of the squamous stratified epithelium, hyperkeratosis, and/or different degrees of ED. Also, in subjacent connective tissue, basophilic degeneration of collagen fibers called solar elastosis is usually detected [22].
Anzeige
According to Dancyger et al., AC pathogenesis is similar to cutaneous actinic keratosis or solar keratosis [23]. In particular, several genes have been implicated in the progression of AC into LSCC, including tumor suppressor gene p53, anti-apoptotic BCL2, Ki-67, and Murine Double Minute 2 (MDM2) tumor-suppressor protein [24]. Although there is a high incidence of UV-specific p53 mutations in both AC (80%) and SCC (90%) [25], p53 protein immunoreactivity has not been considered a marker of the malignant transformation of AC into SCC [26]. On the other hand, the majority of precancerous lesions of the lip, including AC, may not always progress into invasive cancer. Therefore, it is necessary to establish reliable diagnostic histopathologic markers to distinguish precancerous from cancerous lesions and then apply them in clinical practice in order to detect early malignant transformation of the epithelium [27].
Laminin is the most abundant non-collagenous component of all basement membranes [28]. Laminins are a family of heterotrimeric glycoproteins composed of three different gene products, α, β, and γ chains. These chains are assembled into a cross-shaped heterotrimer αβγ3 [28, 29]. There are at least 16 different laminin isoforms named based on the chain composition [29]. The α1 chain together with the β1 and γ1 chains forms the prototypic EHS laminin (laminin-1) and is expressed in different basement membranes [30]. Laminins are involved in several biological processes such as cell differentiation, cell adhesion, migration, proteolytic activity, cell proliferation, and metastatic growth [29‐32]. Under the light microscope, laminin presents a continuous expression in the normal oral mucosa or oral hyperplastic lesions [33, 34]. On the contrary, previous studies suggest a discontinuous distribution of laminin from epithelial hyperplasia to epithelial dysplasia [35‐38]. Cytoplasmic laminin expression levels have also been found to be higher in poorly differentiated aggressive oral SCC [32, 35].
The discontinuous pattern of laminin expression in the basement membrane (BM) as well as the absence of its expression might be useful in the early diagnosis of precancerous lesions of the lips as well as in predicting the biological progression toward malignancy. Therefore, the contribution of laminin to the transformation of AC into LSCC needs further clarification. Here we hypothesized that laminin expression levels are altered during lip carcinogenesis. We also hypothesized that immunohistochemical (IHC) expression of laminin might be a useful diagnostic marker to identify early invasion and distinguish cancerous from precancerous lesions. To investigate our hypothesis, we analyzed laminin expression by IHC analysis in biopsies taken from patients with AC of low-grade and high-grade ED and correlated them with its expression in LSCC biopsies. In order to investigate the possible utility of this marker in the differential diagnosis of precancerous lesions, we examined the integrity of the BM as well as cytoplasmic staining patterns. Understanding the mechanism involved in the progression process of actinic cheilitis into LSCC may provide useful histopathologic markers for its early detection, as well as targets for its therapeutic efficacy to be evaluated by further investigation in larger studies.
Materials and Methods
Tissue Samples
Lip tissue samples were represented by surgical biopsies from 46 patients, 37 males, and 9 females; (mean age of 67 years). These biopsies were performed for diagnostic purposes. The biopsies had been routinely fixed in 10% buffered formalin solution and then processed and embedded in paraffin blocks (FFPE). All biopsies were retrieved from the archived files of the Pathology department at the University of Thessaly, Greece. [Ethical approval (#28,255/06-07-22) was obtained by the local Ethics Committee of the University of Thessaly]. All FFPEs used in this study were documented with unique de-identified identification numbers.
Anzeige
Histopathologic Evaluation
Histologic evaluation was performed by microscopic examination of 3–4 μm tissue sections stained with hematoxylin and eosin (H&E). ED was classified as low or high grade according to the diagnostic criteria provided by World Health Organization (WHO) [38]. According to WHO, ED was classified as low-grade (mild) or high-grade (moderate to severe), based on architectural and cytological criteria. These criteria include changes such as irregular stratification, loss of cellular cohesion, drop-shaped rete ridges, increased nuclear-cytoplasmic ratio, hyperchromatism, nuclear and cellular pleomorphism, typical and atypical mitoses, increased size, the number of nucleoli, dyskeratosis, and keratin pearls. In particular, ED was characterized as low-grade (mild dysplasia) when the cellular atypia alterations were restricted to the basal and parabasal region of the epithelium, not exceeding the inferior third. ED was characterized as high-grade when alterations were extended from the basal layer to the middle-third of the epithelium (moderate dysplasia) or a level above the midpoint, affecting more than two-thirds of the epithelium (severe dysplasia or in situ carcinoma) [39].
Immunohistochemistry
IHC analysis was performed to detect laminin-1, since its expression is largely limited to the epithelial BM [40]. Following previously established protocols [41, 42], 3–4 µm tissue sections were cut from FFPEs using a Leica TP1020 microtome and dried overnight at 60 ℃. After deparaffinization in xylene, the sections were rehydrated in decreasing ethanol solutions. Antigen retrieval was achieved by treating tissue sections with proteinase K for 10 minutes at 37 ℃. After antigen retrieval, the sections were washed in phosphate-buffered saline (PBS). Then they were incubated in 0.3% hydrogen peroxide for 10 minutes to block endogenous peroxidase. Immunostaining was performed with the primary antibody (Laminin, clone LAM89, isotype IgG1, Thermo Scientific, dilution 1:50) for 30 min. A polymer detection system (Genemed Biotechnologies) was then added followed by incubation for 30 min. Bound antibodies were visualized by using 0.05% 3,3′-diaminobenzidine solution (DAB, DAKO). Finally, sections were counterstained with 1% hematoxylin and mounted in DPX mounting medium (BDH Laboratory Supplies, UK). The expression of laminin in the BM of normal surgical margins was considered an internal positive control. Negative controls were performed by omission of the primary antibody and substituting the antibodies with non-immune sera.
Results
Actinic Cheilitis Occurs with Concomitant Low- to High-grade Dysplastic Lesions and/or Invasive Squamous Cell Carcinoma
Microscopic examination of lip tissue sections revealed 34 cases of AC and 12 cases of LSCC. Specifically, microscopic examination of tissue sections stained with H&E revealed 31 AC cases with low-grade dysplasia (Fig. 1A), 3 AC cases with high-grade dysplasia (Fig. 1B), and 12 SCC cases developed in AC (Fig. 1C). Figure 1D shows the percentage of cases that developed ED and/or LSCC in AC.
Fig. 1
Actinic cheilitis (AC with concomitant low-grade to high-grade epithelial dysplastic (ED) lesions or invasive squamous cell carcinoma of the lip (LSCC). Hematoxylin and eosin (H&E) histologic staining. A Actinic cheilitis with low-grade ED (a) Original magnification x40. (b) Original magnification of 200x. B Actinic cheilitis with-high grade ED (original magnification x200). C Invasive LSCC developed in AC (original magnification of x40). D Percentages of cases developed ED and/or LSCC in AC
×
![]()
All specimens that showed the histopathological features of AC were characterized by large hyperchromatic nuclear, abnormal cell shape, abnormal mitosis in parabasal layers, loss of basal cell polarity, a disorder of squamous epithelium stratification, dyskeratosis, and bulbous form shaped rete pegs (Fig. 1A, B). Chronic inflammatory infiltration was also observed. Epithelial atrophy was observed in nine cases (Fig. 1B). The SCC of our study showed neoplastic infiltration into the dermis (Fig. 1C). These cases were developed from AC, the features of which were evident in other epithelial foci.
Laminin Staining of the Basement Membrane is Discontinued in Biopsies with High-grade Epithelial Dysplasia or Invasive Squamous Cell Carcinoma
IHC evaluation for laminin revealed intense and linear staining of the BM in all AC cases with low-grade ED (Fig. 2 A a,b). Laminin staining also revealed the continuation of BM in AC biopsies with high-grade ED/in situ carcinoma, although it appeared less intense than AC with low-grade ED (Fig. 2B a,b). However, IHC evaluation showed focal and weaker staining of laminin at sites of BM with high-grade ED/in situ carcinoma (Fig. 2B-c). Interestingly, cytoplasmic accumulation of laminin immunostaining was observed in squamous cells of parabasal layers in cases of high-grade ED/in situ carcinoma (Fig. 2B-d).
Fig. 2
Laminin immunohistochemical (IHC) staining of the basement membrane (BM) in biopsies of actinic cheilitis (AC) with concomitant epithelial dysplasia (ED) and/or invasive squamous cell carcinoma of the lip (LSCC). A AC with low-grade ED. Continuous linear staining of the BM with laminin; (a) Original magnification 40x; (b) Original magnification x200. B AC with high-grade ED. (a) Original magnification x40; (b) Continuous linear staining of the BM with laminin. Original magnification x200; (c) Focal weak staining of laminin at sites of BM with in situ carcinoma. Original magnification x200. (d) Cytoplasmic laminin staining of parabasal cells in high -grade ED of AC. Original magnification x200. C AC with squamous cell carcinoma of the lip (LSCC). Original magnification x40. (a) Discontinued laminin staining, indicating fragmentation of the BM. (b) Magnification x100. D Cytoplasmic laminin staining in tumor cells. Original magnification x400
×
![]()
On the other hand, IHC evaluation for laminin in invasive LSCC revealed loss of its staining in the invasion front, indicating fragmentation of the BM (Fig. 2 C-a,b). Finally, the tumor cells of all the infiltrating LSCC in our study showed cytoplasmic expression of laminin (Fig. 2D).
Anzeige
Discussion
We present new insights into laminin IHC staining as a diagnostic marker of the progression of AC to invasive LSCC. Specifically, we document the differential staining of laminin in BM between AC with low and high-grade ED or invading LSCC, supporting its use as a histopathologic marker of early neoplastic events and invasion.
The BM is a specialized form of extracellular matrix; its role is to separate the epithelium from underlying connective tissue [43]. Specifically, the BM consists of a mixture of collagens and glycoproteins, such as laminin, that can bind to each other to make a highly cross-linked extracellular matrix [44]. It is known that the integrity of the BM changes during inflammation in order to allow the inflammatory cells enter the epithelium. Most importantly, the BM structure undergoes alterations during neoplastic infiltration of cancer cells [45]. To the best of our knowledge, we present for the first time the differential IHC staining of laminin in AC with ED or LSCC, supporting its role as a useful IHC marker in the differential diagnosis. Specifically, our data showed different patterns of IHC expression of laminin-1 between AC with low-grade ED and AC with high-grade ED/in situ carcinoma and between AC and LSCC developed in AC. According to our findings, diffuse, continuous, and intense laminin staining of the BM is characteristically applied to all biopsies from AC with low-grade ED. Biopsies of AC with high-grade ED/in situ carcinoma also present a continuous expression of laminin, however it may appear less intense, and focal at sites of high-grade/in situ carcinoma than low-grade ED, particularly focally at sites of BM with in situ carcinoma. Based on our data, the development of invasive carcinoma in AC demonstrates loss of laminin expression in the BM, as documented in all LSCC biopsies. Our findings are consistent with previous studies by Garcia et al. which showed a differential expression of laminin between oral precancerous and cancerous lesions, supporting a loss of continuity of laminin expression in the epithelial BM from the development of oral carcinomas [35]. Specifically, Garcia et al. noted laminin underexpression along the BM, in 20% of the biopsies with low-grade dysplasia and 57% in high-grade dysplastic lesions, and 70% of oral SCC.
An interesting finding of our study was the cytoplasmic expression of laminin detected in AC with high-grade dysplasia and in LSCC. Specifically, our IHC evaluation for laminin-1, whose expression is largely limited to the epithelial BM, revealed cytoplasmic staining in the lower third of the high-grade ED in AC and in the cytoplasm of infiltrating tumor cells forming focal nests in the dermis. Our findings may support IHC data for the laminin-5 γ2 chain from other studies, which suggested laminin overexpression during the progression of neoplastic disease in invasive oral cancer [34, 37]. Peixoto da-Silva et al. [46] reported negative cytoplasmic staining of the laminin-5 γ2 chain in AC cases, and they also found a cytoplasmic accumulation of laminin-5 in invading cancer cells. Cytoplasmic expression of the γ2 chain of laminin has been previously observed in various types of malignancies, and Peixoto da-Silva et al. suggested it may be due to laminin proteolysis products during neoplastic transformation [46]. Although the exact meaning of this staining remains unknown, the change of laminin expression pattern from linear at the basal cells in low-grade ED to cytoplasmic at the parabasal cells in high-grade ED/in situ carcinoma, not only demonstrates a surrogate biomarker for distinguishing these entities but probably indicates a shift of receptors and cell-cell adhesion molecules from BM to dysplastic epithelial cells, that might contribute to the degradation of the extracellular matrix at the beginning of an invasion. Large-scale studies with different molecules and possibly a combination of methodologies could clarify this phenomenon.
Conclusion
We suggest that immunochemical analysis of laminin expression can be useful in identifying AC cases suspected of early invasion. Furthermore, we propose that laminin immunostaining may contribute to the differential diagnosis between AC with low and high-grade ED, and between AC and invasive LSCC. Alterations in the staining pattern might provide indirect morphological evidence of BM degradation, indicating malignant transformation. From a clinical point of view, the findings could be particularly useful in selecting patients with a greater tendency to develop squamous cell carcinoma and therefore, providing close follow-up.
Anzeige
Declarations
Conflict of interest
The authors whose names are listed in this article certify that they have NO affiliations with or involvement in any organization or entity with any financial interest, or non-financial interest in the subject matter or materials discussed in this manuscript.
Ethical Approval
Ethical approval (#28255; date of approval 06-07-22) was obtained by the local Ethics Committee of the University of Thessaly given the retrospective nature of the study.
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Anzeige
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.